Cancer Biomarkers Conference VIII

Join us for the Cancer Biomarkers Conference VIII at The University of Texas MD Anderson Cancer Center, ranked the #1 cancer center in the nation for over 20 consecutive years by U.S. News & World Report.

The program brings together experts in pathology, oncology, molecular diagnostics, and translational research to discuss emerging advances in cancer biomarkers and precision oncology.

The conference provides opportunities for scientific exchange and dialogue among academic medicine, laboratory leaders, and the broader healthcare community working to advance biomarker-driven cancer care.

Host:
Donna E. Hansel, MD, PhD
Head, Division of Pathology and Laboratory Medicine

Contact Information:
Questions? Contacts: Dr. Kareen E. Chin ([email protected]) Jeff Mize ([email protected])

Registration Fees:

Exhibitor Registration & Prospectus: Please contact Kareen Chin ([email protected])

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.